1.
Baena Cañada JM, de la Torre Hita C, Bernal Gómez M, Campini Bermejo A, Gámez Casado S, Rodríguez Pérez L, Quílez Cutillas A, Calvete Candenas J, Estalella Mendoza S, Benítez Rodríguez E. Trends in Adjuvant Chemotherapy Use in Endocrine-Sensitive, HER-2 Negative Breast Cancer, With 1 to 3 Positive Nodes: A Single-Centre Study. Arch Breast Cancer [Internet]. 2021 Jul. 27 [cited 2021 Oct. 17];:233-42. Available from: https://archbreastcancer.com/index.php/abc/article/view/409